AI in BioTech
AI in BioTech is a comprehensive platform designed to illuminate the burgeoning intersection of artificial intelligence and biotechnology. This multifaceted hub offers access to groundbreaking AI frameworks, influential investors, industry experts, prominent entities, and cutting-edge research facilities, covering diverse topics from Biomarkers and Drug Discovery to NeuroTech and Space Medicine. Embodying the future of biotech, AI in BioTech serves as the definitive gateway to insights and advancements that shape and propel the industry forward.
AI in BioTech Mindmap
Automatic Labs
Coming Soon
Longevity
Coming Soon
Regenerative Medicine
Coming Soon
FoodTech
Coming Soon
Industrial BioTech
Coming Soon
Enviromental BioTech
Coming Soon
Biocomputers
Pets
Coming Soon
Follow us
AI in BioTech Industry Size Assessment
Experts in the field of AI in BioTech
Our mindmap encapsulates an expansive network of experts in AI in BioTech, spanning computational biologists to neuroscientists and pharmacologists, each applying AI in unique ways. They drive innovation across areas such as Biomarkers, NeuroTech, Drug Discovery, and Space Medicine. This collaborative space amplifies knowledge exchange and accelerates AI's integration into biotech, redefining healthcare's future with their collective expertise and innovative approaches.
AI in BioTech Framework
Can be used for navigation by clicking on the categories.
.png)
.webp)
.png)
Longevity Industry Journal
Longevity Industry 2022 Journal is designed to serve as the first dedicated industry journal for the exponentially expanding Global Longevity Industry, and the first in a series of journals updated and released every financial quarter.The Journal presents up-to-date summaries, investment and sector-specific digests, key market trends and near-future forecasts of the full scope of Longevity Industry developments as of Q1 2022, compressed into quickly understandable summaries and chapters in order to distil only the most important take-aways required for investors, entrepreneurs, medical professionals and practitioners, policy makers, financial executives and other Longevity Industry professionals to optimise their decision making, effectively plan their near-future strategic agendas for 2022 and beyond, and obtain tangible and reliable state-of-the-market intelligence and digests on the continued, multifaceted evolution of the global megatrend of Longevity Industrialization.
Global AI in BioMed Economy Size Assessment
The “Global AI in BioMed Economy Size Assessment” reveals the expansive role of AI across the BioTech and Healthcare sectors. Estimated at USD 2.5T in 2023 and expected to soar to USD 6T by 2027, the report delves into nine vital sectors from MedTech to Industrial BioTech. With AI as a pivotal force, the industry is not only recovering from previous market declines but also leading in innovation, boasting 5,585 patents in areas like diagnostics, genomics, and personalized medicine. To know more about sophisticated role of AI in Those sectors, dive into our new report.
One-Pager
Coming Soon
Teaser
Coming Soon
AI in BioMed
A comprehensive platform AI in BioMed sheds light on the developing nexus between artificial intelligence and biotechnology. Access to ground-breaking AI frameworks, powerful investors, business leaders, well-known organizations, and state-of-the-art research facilities are all available through this complex center, which addresses a range of subjects from biomarkers and drug discovery to neurotech and space medicine.
.png)
.png)
AI Industry Global Economy Size Preliminary Assessment
The Artificial Intelligence sector is experiencing unprecedented growth. U.S. generative AI companies alone have garnered $8 billion in investments between 2020-2022. Our comprehensive analysis projects the global AI economy to reach a staggering $32 trillion by 2027. For a detailed and holistic overview of this burgeoning market, we invite you to access our report on our official website. All pertinent analytics, data, and trends have been systematically consolidated for your research. Stay informed; understand the future trajectory of the AI industry with us.
Global AI Ecosystem – Powered by Deep Knowledge Group
Global AI Ecosystem is a subsidiary of Deep Knowledge Group, a data-driven consortium of commercial and non-profit organizations active on many fronts in the realm of DeepTech and Frontier Technologies (AI, Longevity, BioTech, Pharma, FinTech, GovTech, SpaceTech, FemTech, Data Science, InvestTech), ranging from scientific research to investment, entrepreneurship, analytics, consulting, media, philanthropy and more.
